Back to results
US 8,410,124 B2Granted
Deuterated etravirine
AssigneeConcert Pharmaceuticals, Inc.
InventorCraig E. Masse
Life of this patent
Estimating the term…
Abstract
This disclosure relates to novel di-aryl-pyrimidine (DAPY) compounds and pharmaceutically acceptable salts thereof. This disclosure also provides compositions comprising a compound of this disclosure and the use of such compositions in methods of treating diseases and conditions that are beneficially treated by administering a non-nucleoside reverse transcriptase inhibitor (NNRTI).
Claims15
A compound of the Formula I:
- or a pharmaceutically acceptable salt thereof, wherein:
- Y1 and Y2 are the same and are selected from hydrogen and deuterium;
- Y3, Y4, Y5, and Y6 are independently selected from hydrogen and deuterium;
- and
- each R is —CD3.
2 more elements
Dependencies are inferred from the claim text.